A collaboration between two Barcelona institutions and the Nanomedicine Lab at The University of Manchester – aimed at treating brain disorders such as epilepsy and Parkinson’s Disease – has secured £12m in funding, one of the largest investments to date in the European medical nanotechnology industry.

INBRAIN Neuroelectronics is a spin-out company from the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and the Catalan Institution for Research and Advanced Studies (ICREA), partners of – and supported by – the European Commission’s Graphene Flagship programme.

Read more.

Categories: Industry News